Source: United States Attorneys General 13
On June 11, the ICITAP-Mexico mission provided an update on its impact on the criminal justice system in Baja California Sur. In 2022, the state of Baja California Sur acquired high-tech equipment for its forensic chemistry laboratory for the detection of street and pharmaceutical drugs in biological samples. The equipment uses liquid chromatography coupled with a high-resolution mass spectrometry detector capable of detecting up to 64 drugs in a single sample. Until 2023, it was the only state in Mexico with this technology. The degree of error is so low that it allows experts to differentiate with high precision between one substance and another and even identify new substances that are not reported in databases or libraries which is of vital importance because new drugs appear on the market every day. In addition, sellers have been known to mix various substances and this equipment is sensitive enough to be able to identify them. The Baja California Sur forensic chemistry laboratory achieved ANAB accreditation in January 2020, which guarantees that it operates with internationally recognized standards of quality. For this achievement, ICITAP-Mexico, through its expert advisors, collaborated with the laboratory by providing training, advice and support since 2018. It should be noted that the implementation of a culture of quality standards in forensic services led the state to make an investment for the acquisition of the new technology. ICITAP continues to advise in the development of methods necessary for its proper use. Seven in-state analyses of post-mortem biological samples were recently analyzed in five cases and in all of them fentanyl was identified along with various other drugs. These samples were obtained largely from cases involving foreigners. These different adulterants with fentanyl were identified thanks to the additional scope provided by the new technology. As the only state to have this equipment and methodology until 2023, other states requested support for sample analysis from Baja California Sur including Chihuahua, Morelos, and Tabasco. The presence or lack of drugs in the biological samples have been a factor in the prosecution of various cases in these states. ICITAP wholeheartedly supports this type of collaboration between states. To date Guanajuato, Sonora and the Federal Attorney General’s Office (FGR) have also acquired this technology. The use of this equipment will have many more advantages for Mexico, once the prosecutors’ offices understand the scope of this type of analysis and exploit the capacity of the equipment, but for the moment the ICITAP-trained Baja California Sur laboratory is already capable of responding to increasingly complex situations and cases involving illicit substances. In Mexico, ICITAP works with the support of and in coordination with the U.S. Department of State’s Bureau of International Narcotics and Law Enforcement Affairs (INL).